The US Food and Drug Administration FDA requires Premarket Approval PMA for high-risk class III medical devices where no identifiable predicate exists. PMA regulatory requirements and dossier content is of a much greater complexity for product developers in comparison to alternative 510(k) application file (i.e. need for formal clinical study data, etc.)